background image

Executive Management

[+] Chief Executive Officer
Woosok Lee

Woosok Lee, the President and CEO of TissueGene, brings a broad and multidisciplinary international experience to the company. In addition to his role at TissueGene, Mr. Lee currently serves as the President and CEO of Kolon Pharmaceuticals, Inc., the President and CEO of Kolon ePlatform, Inc., and the President and CEO of Kolon Life Science, Inc. Mr. Lee received his MBA from the UCLA University in Los Angeles, California, and his bachelor’s degree in Economics from the Seoul National University in Korea.

[+] Chief Financial Officer
Yooncheol Yang

In addition to his role as the Chief Financial Officer at TissueGene, Yooncheol Yang currently serves as Chief Financial Officer of Kolon Life Science, Inc. Mr. Yang previously served as the Vice President of the Management & Finance Division at the Kolon Corporation and received his bachelor's degree from Hanyang University in Korea.

[+] Chief Operating Officer
Bumsup Lee, Ph.D

Bumsup Lee, PhD & DVM, joined TissueGene, Inc. in March, 2014 as the Chief Operating Officer. He also serves as a senior vice president and Chief Technology Officer at Kolon Life Science, Inc. He has acquired his expertise in drug development for more than a decade through his previous tenures at biotechs and pharmaceutical companies, Mitokor, Syrrx, and Takeda pharmaceuticals in USA where he advanced multiple drug candidates to clinical stages and commercialization in the areas of diabetes, arthritis, and cancers. He obtained his doctor of veterinary medicine and master of science in pathology degrees from Seoul National University and his PhD in physiology and pharmacology from Iowa State University. He was a postdoctoral fellow at State University of New York at Buffalo medical school.

[+] Chief Medical Officer
Gurdyal Kalsi, M.D.

Gurdyal Kalsi, M.D. is TissueGene's Chief Medical Officer and Senior Vice President for Clinical Development & Medical Affairs. Dr. Kalsi will oversee and direct clinical development, regulatory and medical affairs functions. Dr. Kalsi most recently served as Corporate Vice President for Clinical Development & Medical Affairs at Emergent BioSolutions Inc. He received his medical degrees in surgery and medicine from Glancy Medical School followed by post graduate training in public health medicine at St George's Hospital in London, and Pharmaceutical Medicine specialist training at Cardiff University, UK.

[+] Vice President of R & D
Moon J. Noh, Ph.D

Dr. Moon J. Noh joined TissueGene in 2001 as Vice President of Research and Development. Before joining TissueGene, Dr. Noh was the Director of the Biotechnology Lab at Kolon Central Research Park. Dr. Noh holds a PhD and MS from the Korea Advanced Institute of Science and Technology in Molecular Biology.

[+] General Counsel
Sean Woo, JD

Sean Woo joined TissueGene in 2010 as its General Counsel. Mr. Woo is a graduate of Harvard University and Widener University School of Law. He was an associate at the law firm of Duane, Morris and Hecksher in Wilmington, Delaware, before a long career in the federal government. Mr. Woo is currently a member of the Pennsylvania bar.